Mutant Hras G12V and Kras G12D have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice

Marxa L. Figueiredo, Timothy J. Stein, Adam Jochem, Eric P. Sandgren

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Mouse hepatocarcinogenesis is associated with mutations in Hras, but infrequently in Kras. The effect on carcinogenesis of developmental age at the time of ras mutation remains unknown. Aim: We sought to compare quantitatively the effects of expressing mutant H- or Kras genes in fetal vs. adult mouse liver. Methods: We established an inducible system of gene expression in mouse liver to define disease pathogenesis associated with activation of oncogene expression. Results: Diffuse expression of either oncogene in fetal or adult hepatocytes caused hepatomegaly. For mutant Hras G12V, this phenotype was almost fully reversible and accompanied by apoptosis, indicating that maintenance of hepatomegaly requires continuous Hras G12V expression. We also examined the effect of ras expression on growth of transplanted hepatocytes in an in vivo system that allows us to quantify hepatocyte growth effects in both permissive and restrictive hepatic growth environments. Mutant Kras G12D had no effect on hepatocyte growth in this system. In contrast, Hras G12V induced increased hepatocyte focus growth in quiescent liver, the hallmark of a cell autonomous growth stimulus. Hras G12V also increased the fraction of donor hepatocyte foci that displayed extreme growth, a characteristic of preneoplastic lesions. Conclusions: The primary effect of diffuse, whole-liver expression of either mutant ras gene in fetal or adult mouse liver is diffuse and progressive hepatic growth. Hras G12V mutation influences hepatocarcinogenesis by conferring cell autonomous growth potential upon foci of expressing cells and by increasing the risk of neoplastic progression. Kras G12D does not share these latter carcinogenic effects in mouse liver.

Original languageEnglish
Pages (from-to)582-591
Number of pages10
JournalLiver International
Volume32
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Transgenic Mice
Hepatocytes
Growth
Liver
Hepatomegaly
Oncogenes
Mutation
ras Genes
Carcinogenesis
Maintenance
Apoptosis
Phenotype
Gene Expression
Genes

Keywords

  • Hepatocellular carcinoma
  • Hepatocyte transplantation
  • Hras
  • Kras
  • Oncogene

ASJC Scopus subject areas

  • Hepatology

Cite this

Mutant Hras G12V and Kras G12D have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice. / Figueiredo, Marxa L.; Stein, Timothy J.; Jochem, Adam; Sandgren, Eric P.

In: Liver International, Vol. 32, No. 4, 04.2012, p. 582-591.

Research output: Contribution to journalArticle

Figueiredo, Marxa L. ; Stein, Timothy J. ; Jochem, Adam ; Sandgren, Eric P. / Mutant Hras G12V and Kras G12D have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice. In: Liver International. 2012 ; Vol. 32, No. 4. pp. 582-591.
@article{9d1536f6811e4c028a6f0cb81b7e86ab,
title = "Mutant Hras G12V and Kras G12D have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice",
abstract = "Background: Mouse hepatocarcinogenesis is associated with mutations in Hras, but infrequently in Kras. The effect on carcinogenesis of developmental age at the time of ras mutation remains unknown. Aim: We sought to compare quantitatively the effects of expressing mutant H- or Kras genes in fetal vs. adult mouse liver. Methods: We established an inducible system of gene expression in mouse liver to define disease pathogenesis associated with activation of oncogene expression. Results: Diffuse expression of either oncogene in fetal or adult hepatocytes caused hepatomegaly. For mutant Hras G12V, this phenotype was almost fully reversible and accompanied by apoptosis, indicating that maintenance of hepatomegaly requires continuous Hras G12V expression. We also examined the effect of ras expression on growth of transplanted hepatocytes in an in vivo system that allows us to quantify hepatocyte growth effects in both permissive and restrictive hepatic growth environments. Mutant Kras G12D had no effect on hepatocyte growth in this system. In contrast, Hras G12V induced increased hepatocyte focus growth in quiescent liver, the hallmark of a cell autonomous growth stimulus. Hras G12V also increased the fraction of donor hepatocyte foci that displayed extreme growth, a characteristic of preneoplastic lesions. Conclusions: The primary effect of diffuse, whole-liver expression of either mutant ras gene in fetal or adult mouse liver is diffuse and progressive hepatic growth. Hras G12V mutation influences hepatocarcinogenesis by conferring cell autonomous growth potential upon foci of expressing cells and by increasing the risk of neoplastic progression. Kras G12D does not share these latter carcinogenic effects in mouse liver.",
keywords = "Hepatocellular carcinoma, Hepatocyte transplantation, Hras, Kras, Oncogene",
author = "Figueiredo, {Marxa L.} and Stein, {Timothy J.} and Adam Jochem and Sandgren, {Eric P.}",
year = "2012",
month = "4",
doi = "10.1111/j.1478-3231.2011.02732.x",
language = "English",
volume = "32",
pages = "582--591",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Mutant Hras G12V and Kras G12D have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice

AU - Figueiredo, Marxa L.

AU - Stein, Timothy J.

AU - Jochem, Adam

AU - Sandgren, Eric P.

PY - 2012/4

Y1 - 2012/4

N2 - Background: Mouse hepatocarcinogenesis is associated with mutations in Hras, but infrequently in Kras. The effect on carcinogenesis of developmental age at the time of ras mutation remains unknown. Aim: We sought to compare quantitatively the effects of expressing mutant H- or Kras genes in fetal vs. adult mouse liver. Methods: We established an inducible system of gene expression in mouse liver to define disease pathogenesis associated with activation of oncogene expression. Results: Diffuse expression of either oncogene in fetal or adult hepatocytes caused hepatomegaly. For mutant Hras G12V, this phenotype was almost fully reversible and accompanied by apoptosis, indicating that maintenance of hepatomegaly requires continuous Hras G12V expression. We also examined the effect of ras expression on growth of transplanted hepatocytes in an in vivo system that allows us to quantify hepatocyte growth effects in both permissive and restrictive hepatic growth environments. Mutant Kras G12D had no effect on hepatocyte growth in this system. In contrast, Hras G12V induced increased hepatocyte focus growth in quiescent liver, the hallmark of a cell autonomous growth stimulus. Hras G12V also increased the fraction of donor hepatocyte foci that displayed extreme growth, a characteristic of preneoplastic lesions. Conclusions: The primary effect of diffuse, whole-liver expression of either mutant ras gene in fetal or adult mouse liver is diffuse and progressive hepatic growth. Hras G12V mutation influences hepatocarcinogenesis by conferring cell autonomous growth potential upon foci of expressing cells and by increasing the risk of neoplastic progression. Kras G12D does not share these latter carcinogenic effects in mouse liver.

AB - Background: Mouse hepatocarcinogenesis is associated with mutations in Hras, but infrequently in Kras. The effect on carcinogenesis of developmental age at the time of ras mutation remains unknown. Aim: We sought to compare quantitatively the effects of expressing mutant H- or Kras genes in fetal vs. adult mouse liver. Methods: We established an inducible system of gene expression in mouse liver to define disease pathogenesis associated with activation of oncogene expression. Results: Diffuse expression of either oncogene in fetal or adult hepatocytes caused hepatomegaly. For mutant Hras G12V, this phenotype was almost fully reversible and accompanied by apoptosis, indicating that maintenance of hepatomegaly requires continuous Hras G12V expression. We also examined the effect of ras expression on growth of transplanted hepatocytes in an in vivo system that allows us to quantify hepatocyte growth effects in both permissive and restrictive hepatic growth environments. Mutant Kras G12D had no effect on hepatocyte growth in this system. In contrast, Hras G12V induced increased hepatocyte focus growth in quiescent liver, the hallmark of a cell autonomous growth stimulus. Hras G12V also increased the fraction of donor hepatocyte foci that displayed extreme growth, a characteristic of preneoplastic lesions. Conclusions: The primary effect of diffuse, whole-liver expression of either mutant ras gene in fetal or adult mouse liver is diffuse and progressive hepatic growth. Hras G12V mutation influences hepatocarcinogenesis by conferring cell autonomous growth potential upon foci of expressing cells and by increasing the risk of neoplastic progression. Kras G12D does not share these latter carcinogenic effects in mouse liver.

KW - Hepatocellular carcinoma

KW - Hepatocyte transplantation

KW - Hras

KW - Kras

KW - Oncogene

UR - http://www.scopus.com/inward/record.url?scp=84858283360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858283360&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2011.02732.x

DO - 10.1111/j.1478-3231.2011.02732.x

M3 - Article

VL - 32

SP - 582

EP - 591

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 4

ER -